Atomwise Stock
Atomwise is an artificial intelligence (AI)-driven drug discovery company harnessing the power of deep learning and massive computational resources for the development of novel pharmaceuticals. Its proprietary platform, AtomNet, utilizes techniques mimicking molecular recognition to screen vast libraries of chemical compounds.
Founded: 2012
Management Team
| Abraham Heifets, Ph.D. Co-Founder and CEO |
| Izhar Wallach, Ph.D. Co-Founder and CTO |
| Gavin Hirst, Ph.D. Chief Scientific Officer |
| Neely Mozaffarian, M.D., Ph.D. Chief Medical Officer |
